Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Tuberous Sclerosis 1Recurrence 1Polycystic Ovary Syndrome 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Focal Cortical Dysplasia 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumours 1Advanced Solid Tumors 1

Interventions

Metformin 7Clomiphene 4Progesterone 2Pioglitazone 2Medroxyprogesterone Acetate 2Inositol 2Folic Acid 2Flutamide 2Estrogens 2Estradiol 2salicylsalicylic acid 1ganirelix 1Thioctic Acid 1Sugars 1Resistance Training 1Raloxifene Hydrochloride 1Progestins 1Nutrition Assessment 1Methyltestosterone 1Magnesium 1Linseed Oil 1Leuprolide 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Itraconazole 1Gonadotropins 1Flour 1Fenofibrate 1Exercise 1Docosahexaenoic Acids 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Polycystic Ovary Syndrome × Itraconazole × Clear all
NCT03119077 2018-05-17

Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116

Bayer

Phase 1 Terminated
32 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡